Analysts’ updated eps estimates for Thursday, May 9th:
Aimmune Therapeutics (NASDAQ:AIMT) had its buy rating reissued by analysts at Wedbush. Wedbush currently has a $79.00 target price on the stock.
Get Aimmune Therapeutics Inc alerts: Antero Midstream (NYSE:AM) had its hold rating reaffirmed by analysts at Barclays PLC. They currently have a $16.00 target price on the stock.
ANI Pharmaceuticals (NASDAQ:ANIP) had its buy rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $89.00 price target on the stock. The analysts wrote, “. Post 1Q19, we are reiterating our Overweight rating and raising our 12-month price target to $89 from $74. The company continues to advance its potentially transformational corticotropin product, and has committed to an sNDA filing goal of 1Q2020, while continuing to deliver strong top line growth. If ANIP is successful in gaining approval for this product, and is able to capture a small portion of the Acthar market, we estimate this could result in an additional $150MM+ in revenue for the company. For context, the midpoint of the company’s 2019 revenue guidance is $238MM.””
Aareal Bank (ETR:ARL) had its neutral rating reissued by analysts at DZ Bank AG.
American Axle & Manufact. (NYSE:AXL) had its buy rating reiterated by analysts at Barclays PLC. The firm currently has a $20.00 price target on the stock.
Banco Latinoamericano de Comerci Extr (NYSE:BLX) had its buy rating reissued by analysts at Raymond James. They currently have a $25.00 price target on the stock.
BayWa AG/AKT o.N. (ETR:BYW6) had its neutral rating reiterated by analysts at DZ Bank AG.
Deutsche Telekom (FRA:DTE) had its buy rating reiterated by analysts at DZ Bank AG.
Fielmann (FRA:FIE) had its sell rating reissued by analysts at DZ Bank AG.
Gates Industrial (NYSE:GTES) had its hold rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $17.00 price target on the stock.
ICF International (NASDAQ:ICFI) had its price target boosted by Barrington Research from $86.00 to $88.00. The firm currently has an outperform rating on the stock. The analysts wrote, “We are raising our 12-month price target to $88 (from $86), which conservatively assumes an EV/NTM EBITDA multiple of 12x. The average EV/NTM EBITDA multiple for the government consulting peer group is 12.5x and 14.4x for the specialty consulting peer group. We reiterate our OUTPERFORM rating. Opinion OUTPERFORM (12 mo) $88 17% LT EPS Cap (mil) $1,451 Enterprise Value (mil) $1,678 Shares Outstanding (mil) 19.3 Volume 99,323 Financial / Valuation Adjusted ROE (LTM) 10.0% LT Debt/Capital 26.0% EV/Adj.””
Mosaic (NYSE:MOS) had its hold rating reiterated by analysts at Barclays PLC. The firm currently has a $28.00 price target on the stock.
CECONOMY AG/ADR (OTCMKTS:MTTRY) had its neutral rating reissued by analysts at DZ Bank AG.
MTU Aero Engines (ETR:MTX) was given a €225.00 ($261.63) price target by analysts at JPMorgan Chase & Co.. The firm currently has a buy rating on the stock.
Odeon Capital Group LLC initiated coverage on shares of Nutanix (NASDAQ:NTNX) . They issued a buy rating on the stock.
Pfizer (NYSE:PFE) had its hold rating reissued by analysts at Barclays PLC. The firm currently has a $41.00 price target on the stock.
Prosiebensat 1 Media (ETR:PSM) had its neutral rating reaffirmed by analysts at DZ Bank AG.
Palatin Technologies (NYSEAMERICAN:PTN) had its price target boosted by HC Wainwright from $5.00 to $6.00. They currently have a buy rating on the stock.
Qorvo (NASDAQ:QRVO) had its buy rating reissued by analysts at Barclays PLC. Barclays PLC currently has a $80.00 price target on the stock.
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its buy rating reissued by analysts at Barclays PLC.
Sailpoint Technologies (NYSE:SAIL) had its hold rating reissued by analysts at Canaccord Genuity. They currently have a $20.00 target price on the stock, down from their previous target price of $29.00.
Select Medical (NYSE:SEM) had its hold rating reaffirmed by analysts at Barclays PLC. They currently have a $16.00 price target on the stock.
Sixt (ETR:SIX2) was given a €125.00 ($145.35) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.
Sixt (ETR:SIX2) had its buy rating reaffirmed by analysts at DZ Bank AG.
Stamps.com (NASDAQ:STMP) had its sell rating reissued by analysts at Roth Capital. They currently have a $35.00 price target on the stock, down from their previous price target of $78.00.
Talanx (ETR:TLX) had its buy rating reissued by analysts at DZ Bank AG.
Receive News & Ratings for Aimmune Therapeutics Inc analysts' ratings for Aimmune Therapeutics Inc and related companies daily email newsletter .
